Results 21 to 30 of about 16,028,191 (346)

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market. [PDF]

open access: yesEinstein (Sao Paulo), 2018
The manufacturing process for biological products is complex, expensive and critical to the final product, with an impact on their efficacy and safety. They have been increasingly used to treat several diseases, and account for approximately 50% of the ...
Scheinberg MA   +4 more
europepmc   +2 more sources

Impact of Aggregation on the Immunogenicity of Therapeutic Recombinant Biological Products. [PDF]

open access: goldPharmaceuticals (Basel)
Chen X   +8 more
europepmc   +2 more sources

Biological Activities of Natural Products III [PDF]

open access: yes, 2023
The search for natural products that display biological activity is invariably an attractive research area for scientific centers and teams from around the world [...
Szopa, Agnieszka   +3 more
core   +1 more source

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants

open access: yesHuman Vaccines & Immunotherapeutics, 2023
COVID-19 pandemic caused by SARS-CoV-2 infection has an impact on global public health and social economy. The emerging immune escape of SARS-CoV-2 variants pose great challenges to the development of vaccines based on original strains.
Feixia Gao   +10 more
doaj   +1 more source

Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice

open access: yesVirology Journal, 2023
Mpox (monkeypox) infection cases increased recently in non-Mpox outbreak areas, potentially causing an international threat. The desire to defend against a potential outbreak has led to renewed efforts to develop Mpox vaccines.
Feixia Gao   +10 more
doaj   +1 more source

Current Industry Best Practice on In-Use Stability and Compatibility Studies for Biological Products.

open access: yesJournal of Pharmacy and Science, 2023
Evaluating the in-use stability of a biological product including its compatibility with administration components allows to define handling instructions and potential hold times that retain product quality during dose preparation and administration. The
Markus Blümel   +17 more
semanticscholar   +1 more source

Considerations for the design and conduct of externally controlled trials for drug and biological products

open access: yesReal-World Data & Evidence, 2023
This guidance provides recommendations to sponsors and investigators considering the use of externally controlled clinical trials to provide evidence of the safety and effectiveness of a drug product.
A. S. Motrinchuk, D. Belousov
semanticscholar   +1 more source

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models

open access: yesHuman Vaccines & Immunotherapeutics, 2022
The DTacP-sIPV-Hib combination vaccine can replace the single-component acellular pertussis, diphtheria, tetanus, polio, and Haemophilus influenzae type B vaccines. In this study, we evaluated the safety and immunogenicity of a newly developed DTacP-sIPV-
Yuntao Zhang   +14 more
doaj   +1 more source

AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses

open access: yesVaccines, 2022
Since some cases of human infections with H5N8 avian influenza virus have been reported and caused great concern in recent years, it is important to develop an effective vaccine for human use to prevent a potential H5N8 pandemic.
Feixia Gao   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy